Government
Drug firm settles New York lawsuit over Paxil data
NEWS IN BRIEF — Posted Sept. 13, 2004
GlaxoSmithKline in August agreed to pay New York $2.5 million to settle a lawsuit in which the state attorney general accused the pharmaceutical company of concealing information that would have alerted doctors that the antidepressant Paxil could be harmful to children or adolescents.
In an Aug. 26 statement, GlaxoSmithKline said the accusations were "unfounded" and that it had agreed to settle the lawsuit to "avoid the high costs and time required to defend itself."
Amid public concern about what studies showed, the company on June 10 posted the full results from all of its Paxil trials that involved children and adolescents. On June 18, GlaxoSmithKline announced plans to provide open Internet access to clinical trial data on all of its medications, something the company said had been under way for months.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2004/09/13/gvbf0913.htm.












